Global Digital Pathology 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01250833

Publication Date:

January 17, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Digital Pathology market size is predicted to grow from US$ 911 million in 2025 to US$ 1956 million in 2031; it is expected to grow at a CAGR of 13.6% from 2025 to 2031.
Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.
The digital pathology market is experiencing significant growth and transformation, influenced by technological advancements, evolving healthcare needs, and increasing adoption of digital solutions in pathology. Here are the key trends shaping this market:
1. Growing Demand for Telepathology
The shift towards telehealth, accelerated by the COVID-19 pandemic, has driven demand for telepathology solutions. Digital pathology systems facilitate remote consultations and collaborations, enabling pathologists to access and review cases from various locations.
2. Technological Advancements
Continuous innovations in imaging technology, such as higher-resolution scans, faster processing speeds, and improved automation, are enhancing the capabilities of digital pathology systems. The integration of artificial intelligence (AI) and machine learning is also revolutionizing image analysis and diagnostics.
3. Regulatory Approvals and Support
Increasing regulatory approvals for digital pathology systems for primary diagnosis are fostering confidence in these technologies. Regulatory bodies like the FDA are recognizing the potential of digital pathology, encouraging wider acceptance in clinical practice.
4. Investment in Healthcare IT Infrastructure
Healthcare institutions are investing heavily in digital solutions to modernize their pathology labs. This trend aims to improve laboratory efficiency, accuracy, and patient care, driving demand for digital pathology systems.
5. Focus on Personalized Medicine
Digital pathology plays a crucial role in personalized medicine by integrating pathology data with genomic and clinical information. This trend is promoting the development and adoption of systems that support tailored treatment approaches.
The 鈥淒igital Pathology Industry Forecast鈥� looks at past sales and reviews total world Digital Pathology sales in 2024, providing a comprehensive analysis by region and market sector of projected Digital Pathology sales for 2025 through 2031. With Digital Pathology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Pathology industry.
This Insight Report provides a comprehensive analysis of the global Digital Pathology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Pathology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Digital Pathology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Pathology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Pathology.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Pathology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Whole Slide Imaging
Image Analysis-Informatics
Information Management System Storage & Communication
Digital IVD Devices
Others
Segmentation by Application:
Pharma & Biotech Companies
Hospital & Diagnostic Centers
Educational Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher
Hamamatsu Photonics
Roche
Philips
Olympus
PerkinElmer
Sectra
Nikon
Definiens
3DHISTECH
Visiopharm
Apollo Enterprise Imaging
Glencoe Software
Indica Labs
OptraSCAN
Objective Pathology
Digipath
Pathcore

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Digital Pathology 麻豆原创 Size (2020-2031)
2.1.2 Digital Pathology 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Digital Pathology by Country/Region (2020, 2024 & 2031)
2.2 Digital Pathology Segment by Type
2.2.1 Whole Slide Imaging
2.2.2 Image Analysis-Informatics
2.2.3 Information Management System Storage & Communication
2.2.4 Digital IVD Devices
2.2.5 Others
2.3 Digital Pathology 麻豆原创 Size by Type
2.3.1 Digital Pathology 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Digital Pathology 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Digital Pathology Segment by Application
2.4.1 Pharma & Biotech Companies
2.4.2 Hospital & Diagnostic Centers
2.4.3 Educational Institutes
2.5 Digital Pathology 麻豆原创 Size by Application
2.5.1 Digital Pathology 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Digital Pathology 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Digital Pathology 麻豆原创 Size by Player
3.1 Digital Pathology 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Digital Pathology Revenue by Player (2020-2025)
3.1.2 Global Digital Pathology Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Digital Pathology Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Pathology by Region
4.1 Digital Pathology 麻豆原创 Size by Region (2020-2025)
4.2 Global Digital Pathology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Digital Pathology 麻豆原创 Size Growth (2020-2025)
4.4 APAC Digital Pathology 麻豆原创 Size Growth (2020-2025)
4.5 Europe Digital Pathology 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Digital Pathology 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Digital Pathology 麻豆原创 Size by Country (2020-2025)
5.2 Americas Digital Pathology 麻豆原创 Size by Type (2020-2025)
5.3 Americas Digital Pathology 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Pathology 麻豆原创 Size by Region (2020-2025)
6.2 APAC Digital Pathology 麻豆原创 Size by Type (2020-2025)
6.3 APAC Digital Pathology 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Pathology 麻豆原创 Size by Country (2020-2025)
7.2 Europe Digital Pathology 麻豆原创 Size by Type (2020-2025)
7.3 Europe Digital Pathology 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Pathology by Region (2020-2025)
8.2 Middle East & Africa Digital Pathology 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Digital Pathology 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Digital Pathology 麻豆原创 Forecast
10.1 Global Digital Pathology Forecast by Region (2026-2031)
10.1.1 Global Digital Pathology Forecast by Region (2026-2031)
10.1.2 Americas Digital Pathology Forecast
10.1.3 APAC Digital Pathology Forecast
10.1.4 Europe Digital Pathology Forecast
10.1.5 Middle East & Africa Digital Pathology Forecast
10.2 Americas Digital Pathology Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Digital Pathology Forecast
10.2.2 Canada 麻豆原创 Digital Pathology Forecast
10.2.3 Mexico 麻豆原创 Digital Pathology Forecast
10.2.4 Brazil 麻豆原创 Digital Pathology Forecast
10.3 APAC Digital Pathology Forecast by Region (2026-2031)
10.3.1 China Digital Pathology 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Digital Pathology Forecast
10.3.3 Korea 麻豆原创 Digital Pathology Forecast
10.3.4 Southeast Asia 麻豆原创 Digital Pathology Forecast
10.3.5 India 麻豆原创 Digital Pathology Forecast
10.3.6 Australia 麻豆原创 Digital Pathology Forecast
10.4 Europe Digital Pathology Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Digital Pathology Forecast
10.4.2 France 麻豆原创 Digital Pathology Forecast
10.4.3 UK 麻豆原创 Digital Pathology Forecast
10.4.4 Italy 麻豆原创 Digital Pathology Forecast
10.4.5 Russia 麻豆原创 Digital Pathology Forecast
10.5 Middle East & Africa Digital Pathology Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Digital Pathology Forecast
10.5.2 South Africa 麻豆原创 Digital Pathology Forecast
10.5.3 Israel 麻豆原创 Digital Pathology Forecast
10.5.4 Turkey 麻豆原创 Digital Pathology Forecast
10.6 Global Digital Pathology Forecast by Type (2026-2031)
10.7 Global Digital Pathology Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Digital Pathology Forecast
11 Key Players Analysis
11.1 Danaher
11.1.1 Danaher Company Information
11.1.2 Danaher Digital Pathology Product Offered
11.1.3 Danaher Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Danaher Main Business Overview
11.1.5 Danaher Latest Developments
11.2 Hamamatsu Photonics
11.2.1 Hamamatsu Photonics Company Information
11.2.2 Hamamatsu Photonics Digital Pathology Product Offered
11.2.3 Hamamatsu Photonics Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Hamamatsu Photonics Main Business Overview
11.2.5 Hamamatsu Photonics Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Digital Pathology Product Offered
11.3.3 Roche Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Philips
11.4.1 Philips Company Information
11.4.2 Philips Digital Pathology Product Offered
11.4.3 Philips Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Philips Main Business Overview
11.4.5 Philips Latest Developments
11.5 Olympus
11.5.1 Olympus Company Information
11.5.2 Olympus Digital Pathology Product Offered
11.5.3 Olympus Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Olympus Main Business Overview
11.5.5 Olympus Latest Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Company Information
11.6.2 PerkinElmer Digital Pathology Product Offered
11.6.3 PerkinElmer Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 PerkinElmer Main Business Overview
11.6.5 PerkinElmer Latest Developments
11.7 Sectra
11.7.1 Sectra Company Information
11.7.2 Sectra Digital Pathology Product Offered
11.7.3 Sectra Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Sectra Main Business Overview
11.7.5 Sectra Latest Developments
11.8 Nikon
11.8.1 Nikon Company Information
11.8.2 Nikon Digital Pathology Product Offered
11.8.3 Nikon Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Nikon Main Business Overview
11.8.5 Nikon Latest Developments
11.9 Definiens
11.9.1 Definiens Company Information
11.9.2 Definiens Digital Pathology Product Offered
11.9.3 Definiens Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Definiens Main Business Overview
11.9.5 Definiens Latest Developments
11.10 3DHISTECH
11.10.1 3DHISTECH Company Information
11.10.2 3DHISTECH Digital Pathology Product Offered
11.10.3 3DHISTECH Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 3DHISTECH Main Business Overview
11.10.5 3DHISTECH Latest Developments
11.11 Visiopharm
11.11.1 Visiopharm Company Information
11.11.2 Visiopharm Digital Pathology Product Offered
11.11.3 Visiopharm Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Visiopharm Main Business Overview
11.11.5 Visiopharm Latest Developments
11.12 Apollo Enterprise Imaging
11.12.1 Apollo Enterprise Imaging Company Information
11.12.2 Apollo Enterprise Imaging Digital Pathology Product Offered
11.12.3 Apollo Enterprise Imaging Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Apollo Enterprise Imaging Main Business Overview
11.12.5 Apollo Enterprise Imaging Latest Developments
11.13 Glencoe Software
11.13.1 Glencoe Software Company Information
11.13.2 Glencoe Software Digital Pathology Product Offered
11.13.3 Glencoe Software Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Glencoe Software Main Business Overview
11.13.5 Glencoe Software Latest Developments
11.14 Indica Labs
11.14.1 Indica Labs Company Information
11.14.2 Indica Labs Digital Pathology Product Offered
11.14.3 Indica Labs Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Indica Labs Main Business Overview
11.14.5 Indica Labs Latest Developments
11.15 OptraSCAN
11.15.1 OptraSCAN Company Information
11.15.2 OptraSCAN Digital Pathology Product Offered
11.15.3 OptraSCAN Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 OptraSCAN Main Business Overview
11.15.5 OptraSCAN Latest Developments
11.16 Objective Pathology
11.16.1 Objective Pathology Company Information
11.16.2 Objective Pathology Digital Pathology Product Offered
11.16.3 Objective Pathology Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Objective Pathology Main Business Overview
11.16.5 Objective Pathology Latest Developments
11.17 Digipath
11.17.1 Digipath Company Information
11.17.2 Digipath Digital Pathology Product Offered
11.17.3 Digipath Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Digipath Main Business Overview
11.17.5 Digipath Latest Developments
11.18 Pathcore
11.18.1 Pathcore Company Information
11.18.2 Pathcore Digital Pathology Product Offered
11.18.3 Pathcore Digital Pathology Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Pathcore Main Business Overview
11.18.5 Pathcore Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.